These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16222612)

  • 21. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
    de Paula FJ; Soares JM; Haidar MA; de Lima GR; Baracat EC
    Maturitas; 2007 Jan; 56(1):69-77. PubMed ID: 16822626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopause and cardiovascular disease: the evidence.
    Rosano GM; Vitale C; Marazzi G; Volterrani M
    Climacteric; 2007 Feb; 10 Suppl 1():19-24. PubMed ID: 17364594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women.
    Rossi R; Turco V; Origliani G; Modena MG
    J Hypertens; 2006 Oct; 24(10):2017-22. PubMed ID: 16957562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women].
    Ohta H
    Clin Calcium; 2007 Sep; 17(9):1315-24. PubMed ID: 17767019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC
    Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome among postmenopausal women in Ecuador.
    Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
    Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and the menopause.
    Wedisinghe L; Perera M
    Maturitas; 2009 Jul; 63(3):200-3. PubMed ID: 19535207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?
    Korytkowski MT; Krug EI; Daly MA; Deriso L; Wilson JW; Winters SJ
    Metabolism; 2005 Dec; 54(12):1626-31. PubMed ID: 16311096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological and functional changes of cardiovascular system in postmenopausal women.
    Alessandri N; Piccioni MG; Isabelli V; Alessandri G; Di Matteo A; Padovani D; Rondoni G; Camardella B; Parlapiano C
    Eur Rev Med Pharmacol Sci; 2007; 11(2):107-17. PubMed ID: 17552140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of hormone replacement therapy on the main fatty acids of serum and phospholipids of postmenopausal women.
    Piperi C; Tzivras M; Kalofoutis C; Skenderi A; Michalaki V; Kalofoutis A
    In Vivo; 2005; 19(6):1081-5. PubMed ID: 16277026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.
    Salpeter SR; Walsh JM; Ormiston TM; Greyber E; Buckley NS; Salpeter EE
    Diabetes Obes Metab; 2006 Sep; 8(5):538-54. PubMed ID: 16918589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with Type 2 diabetes.
    Naziroğlu M; Simşek M; Simşek H; Aydilek N; Ozcan Z; Atilgan R
    Clin Chim Acta; 2004 Jun; 344(1-2):63-71. PubMed ID: 15149872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal, subjective, and neurocognitive responses to brief hypoglycemia in postmenopausal women and age-matched men with type 2 diabetes mellitus.
    Bremer JP; Baron M; Peters H; Oltmanns KM; Kern W; Fehm HL; Born J; Schultes B
    Metabolism; 2006 Mar; 55(3):331-8. PubMed ID: 16483876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
    Pirimoglu ZM; Aygun E; Dansuk R; Kucukercan I; Unal O; Turan C
    Gynecol Endocrinol; 2005 Sep; 21(3):185-8. PubMed ID: 16335913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal hormone therapy and the risk of venous thromboembolism.
    Rachoń D; Teede H
    Climacteric; 2008 Aug; 11(4):273-9. PubMed ID: 18645692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.